Sort   by:  
 Page size 
UnknownIntegration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies.
Not available
S-EPMC10815977 | biostudies-literature
UnknownCell-free chromatin immunoprecipitation can determine tumor gene expression in lung cancer patients.
Not available
S-EPMC10158780 | biostudies-literature
UnknownEarly Change in FDG-PET Signal and Plasma Cell-Free DNA Level Predicts Erlotinib Response in EGFR Wild-Type NSCLC Patients.
Not available
S-EPMC5094375 | biostudies-literature
UnknownGenomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer Patients.
Not available
S-EPMC7226192 | biostudies-literature
UnknownTumoral PD-L1 does not impact time to treatment discontinuation in EGFR mutated non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitor-a Danish cohort study.
Not available
S-EPMC9554682 | biostudies-literature
UnknownGene Expression of the EGF System-a Prognostic Model in Non-Small Cell Lung Cancer Patients Without Activating EGFR Mutations.
Not available
S-EPMC5006812 | biostudies-literature
UnknownCirculating immune response proteins predict the outcome following disease progression of osimertinib treated epidermal growth factor receptor-positive non-small cell lung cancer patients.
Not available
S-EPMC9903085 | biostudies-literature
UnknownCorrelation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients.
Not available
S-EPMC5572172 | biostudies-literature
UnknownCan liquid biopsy dynamics stratify patients with small cell lung cancer?
Not available
S-EPMC10774997 | biostudies-literature
UnknownQuantities of comorbidities affects physical, but not mental health related quality of life in type 1 diabetes with confirmed polyneuropathy.
Not available
S-EPMC6379728 | biostudies-literature
Sort   by:  
 Page size